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A B S T R A C T
Myoclonic epilepsy in infancy (MEI) is a primary generalized epilepsy. According to the literature, the
outcome of MEI is usually benign. Here we report a patient who developed myoclonic astatic epilepsy at
age four, having been seizure free without antiepileptic drug treatment for 2 years after his recovery from
MEI. At age four, a video-EEG-recording showed frequent head nodding (atonic seizures) and myoclonic
astatic seizures associated with diffuse spikes or polyspikes and waves. The interictal EEG revealed
frequent bursts of generalized 100–200 mV, 2–4 Hz spike-and-slow-wave complexes. Despite a general
favorable outcome, more severe epilepsy syndromes may develop after MEI, and mental retardation is
sometimes observed. Our case and the previous literature suggest that epilepsies following on from MEI
often involve myoclonic seizures.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eizMyoclonic epilepsy in infancy (MEI), formerly called benign
myoclonic epilepsy in infancy, is a primary generalised epilepsy
characterised by brief, generalised myoclonic seizures (MSs)
occurring during the ﬁrst 2 years of life in normal children. Ictal
EEGs show brief bursts of generalised spikes and waves or
polyspikes and waves. Despite a typically favourable outcome,
epilepsies may follow MEI, and mental retardation is occasionally
observed.1
We have previously reported the electroclinical features and
long-term follow-up of 34 patients with MEI.1 Three patients later
experienced another epilepsy syndrome, while 6 experienced a
single seizure, mostly commonly a febrile seizure. In two patients,
juvenile myoclonic epilepsy (JME) developed at the ages of 9 and
12 years. The latter developed cryptogenic partial epilepsy
12 months after a ﬁrst generalised seizure at the age of 6 years.
A single attack of generalised tonic–clonic seizure has also been
reported, while epilepsy after MEI is infrequent. Recently, a patient* Corresponding author at: Service de Neurologie Pe´diatrique et des Maladies
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doi:10.1016/j.seizure.2012.01.011with MEI who later developed a childhood absence epilepsy has
been reported.2
Here we report a patient who developed myoclonic astatic
epilepsy (MAE) at the age of 4 years. The patient previously had
MEI and then remained without any treatment for 2 years.
1. Case report
A previously healthy 13-month-old boy presented with
myoclonus. Some myoclonia were triggered by tactile and acoustic
stimulations. The patient did not have a notable familial history. He
had never experienced a febrile seizure. A neurological examina-
tion was normal. The patient’s developmental skills were normal.
An electroencephalogram revealed generalised polyspike wave
activity both with and without a clinical correlation (Fig. 1). The
patient was diagnosed with MEI. Treatment with valproate
(30 mg/kg/d) resulted in the cessation of the myoclonic episodes
after one week. Valproate was stopped at the age of 25 months.
The child was seizure-free until the age of 4 years. Brief head
nodding then began without any precursory events. The head
nodding was occasionally preceded by neck extension. The patient
would also occasionally fall suddenly to the ground. Noctural
generalised tonic–clonic seizures were also reported. Atypical
absence was never observed. An interictal electroencephalographyvier Ltd. All rights reserved.
Fig. 1. Ictal polygraphic EEG recording showing spike-wave discharges with two successive myoclonia of the deltoid muscles (EMG 1 right and 2 left).
Fig. 2. Four-year-old male with previous MEI (seizure-free for 2 years). An interictal bipolar longitudinal EEG after the onset of head-drop seizures displays frequent bursts of
generalised 100–200 mV, 2–4 Hz slow and sharp waves.
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Fig. 3. Four-year-old male with previous MEI (seizure-free for 2 years). Ictal bipolar longitudinal video-electroencephalogram recording at time of head-drop seizure. The
electromyographic (EMG) recording of the deltoid muscles showed two myoclonia. The EMG discharges were restored during head nodding, but we did not record the cervical
muscles. The EEG showed bilateral synchronous spike and wave discharges (2.5–3 Hz).
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2–4 Hz spike-and-slow-wave complexes. No focal background
slowing or focal epileptiform discharges were observed (Fig. 2). On
video-EEG recording, frequent nodding (atonic seizures) and
myoclonic astatic seizures were observed with diffuse spikes or
polyspikes and waves (Fig. 3). MRI, genetic and metabolic studies
were normal.
Valproate was ﬁrst administered without any signiﬁcant effect.
Lamotrigine and ethosuximide were successively added to valproate
with limited efﬁcacy. When topiramate was added, the combination
of the three drugs (valproate, lamotrigine and topiramate) decreased
the seizure frequency. The patient began to be seizure-free at age of
5. At 7 years of age, the child is seizure-free under topiramate
monotherapy. His psychomotor development is normal.
2. Discussion
The outcome of MEI is generally benign. Despite a typically
favourable neuropsychological outcome, mental retardation can
be observed more frequently than in the general population.1 Thenew syndrome classiﬁcation (2006) renamed this syndrome MEI
instead of benign myoclonic epilepsy in infancy. Dravet and Bureau
reported the follow-up of 79 cases. The length of the follow-up was
5 years in 63 cases.3 MSs disappeared in all cases. The occurrence
of rare generalised tonic–clonic seizures (GTCS) was reported in 11
patients. Few patients were described with epilepsy after a free
interval. We previously reported two patients with JME; one of
these patients had cryptogenic partial epilepsy.1 Other authors
have reported absences in two children.3 More recently, childhood
absence epilepsy has been reported.2 Here, we ﬁrst report a patient
with MAE following MEI (this patient was seizure-free at the time
of our previous study).1
The modiﬁed ILAE criteria for MAE is as follows: (1) normal
development before the onset of epilepsy and absence of organic
cerebral abnormalities; (2) onset of myoclonic, myoclonic–
astatic, or astatic seizures between 7 months and 6 years of
age; (3) presence of generalised spike- or polyspike-wave EEG
discharges at 2–3 Hz without focal spike discharges; and (4)
exclusion of benign myoclonic epilepsy, severe myoclonic
epilepsy, and cryptogenic Lennox–Gastaut syndrome based on
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except for the last criterion. MAE began in our patient at the age of
4 years, which is consistent with the peak onset of around 3 years
of age.5 The clinical evolution, EEG characteristics, clinical
symptoms and investigations conducted at the onset of myoclonic
astatic seizures permitted the exclusion other diagnoses.
We observed frequent atonic seizures (head nodding) in
addition to classical myoclonic astatic seizures. The occurrence
of pure atonic seizures has been reported in patients with MAE.
Oguni et al. reported 30 patients who fulﬁlled the modiﬁed ILAE
criteria for MAE. They identiﬁed myoclonic seizures in 16 cases,
atonic seizures with or without preceding minor myoclonus in 11
cases, and myoclonic–atonic seizures in three cases. An analysis of
the ictal EEGs showed that all attacks corresponded with
generalised spike or polyspikes-and-wave complexes. In the atonic
form, the spike-and-wave morphology is characterised by a
positive-negative-deep-positive wave followed by a large negative
slow wave.6
The diagnosis in our patient was MAE following MEI. The
relationship between MEI and other myoclonic epilepsies has
been previously discussed. We have previously reported two
patients with MEI followed by JME.1 This association has also
been reported in one patient by others.7 Darra et al. also
described an 18-year-old patient who stopped treatment at the
age of 7 years and experienced GTCS at the age of 14. He did not
receive any treatment after the age of 10 years. This patient had
experienced massive myoclonic jerks induced only by intermit-
tent photic stimulation since the age of 14 years.8 However,
familial epilepsies with myoclonic epilepsy illustrate the
relationship between MEI and myoclonic epilepsies. Arzimano-
glou et al. reported a family that had one member with MEI
and another with MAE.9 Doose mentioned a patient with
previous MAE who had two children. The ﬁrst child had MAE,
and the second child had MEI.10 The development of MAE
detected in our patient provides additional data on the outcome
of MEI.
Our patient ﬁrst had MEI with reﬂex-induced myoclonic
seizures. Some authors have proposed classifying reﬂex MEI as a
separate entity that differs from the non-reﬂex form of MEI in some
distinctive electroclinical features.3 It has also been suggested that
reﬂex MEI leads to a good prognosis. In our previous study, one-
third of patients had reﬂex-induced myoclonic seizures.1 Assuggested by Dravet and Bureau, we do not support the
designation of a separate syndrome with reﬂex seizures.3
The International League Against Epilepsy (ILAE) commission
report in 2001 described ‘‘a benign epilepsy [as]. . .a syndrome
characterized by epileptic seizures that are easily treated, or
require no treatment, and remit without sequelae’’.11 Child
neurologists should be aware that MEI is generally benign, but
alternative outcomes may be observed, such as other epileptic
syndromes and/or mental retardation. Epilepsies following MEI are
most frequently generalised epilepsy syndromes and more
frequently involve myoclonic seizures. We suggest that MEI and
the epilepsy syndrome occurring after MEI likely share some
common neurobiological and genetic substrates.
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